Crew Capital Management, Ltd. Eli Lilly & CO Transaction History

Crew Capital Management, Ltd.

$123 Million
Q3 2024

A detailed history of Crew Capital Management, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Crew Capital Management, Ltd. holds 353 shares of LLY stock, worth $280,871. This represents 0.25% of its overall portfolio holdings.

Number of Shares

353

Previous 8,097 95.64%

Holding current value

$280,871

Previous $7.33 Million 95.74%

% of portfolio

0.25%

Previous 5.93%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $5.98 Million - $7.43 Million	-7,744 Reduced 95.64%	353 $312,000
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $59,439 - $74,541	-82 Reduced 1.0%	8,097 $7.33 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $567,919 - $759,796	-959 Reduced 10.49%	8,179 $6.36 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $43,590 - $51,387	-83 Reduced 0.9%	9,138 $5.33 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $128,236 - $176,793	-295 Reduced 3.1%	9,221 $4.95 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $351,090 - $469,448	-1,001 Reduced 9.52%	9,516 $4.46 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $5,280 - $6,201	-17 Reduced 0.16%	10,517 $3.61 Million
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $2,572 - $2,997	-8 Reduced 0.08%	10,534 $0
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $140,814 - $174,996	-600 Reduced 5.39%	10,542 $3.02 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $11,242 - $13,952	50 Added 0.45%	11,142 $3.08 Million
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $1.82 Million - $2.36 Million	11,092 New	11,092 $2.07 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crew Capital Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Crew Capital Management, Ltd. with notifications on news.

Account

Crew Capital Management, Ltd. Eli Lilly & CO Transaction History